|Articles|June 29, 2023
DIA 2023: Keeping Patients Informed
Jean Sposaro, program lead, TransCelerate BioPharma, and director, global drug development operations industry collaborations, Bristol Myers Squibb speaks about keeping patients informed at the 2023 DIA annual meeting in Boston, MA.
Advertisement
In an interview at the 2023 DIA annual meeting with ACT editor, Andy Studna, Jean Sposaro, program lead, TransCelerate BioPharma, and director, global drug development operations industry collaborations, Bristol Myers Squibb discusses riaising awareness about clinical trials and increasing the public's trust in them.
Newsletter
Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
Reasoning About Individual Drug Causality in a Multifactorial World
2
Why Trial Competition Is Undermining AI-Driven Gains
3
ACT Brief: Recalibrating Trial Efficiency and Access, Verana-COTA Merge to Expand RWE Scale, and FDA Rejects Hetlioz Jet Lag Indication
4
Reframing Efficiency to Protect Patient Access in 2026
5